instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

Covid-19 vaccine rules may change from 2025: What you should know

FDA Panel Recommends Monovalent COVID Vaccine for Next Season | MedPage Today

Astellas Pharma and Pfizer's Xtandi shows long-term survival in prostate cancer | Markets Insider

Was Jim Cramer Right About Pfizer Inc. (PFE)?
FDA: Add Heart Risk to COVID Shot Warning Label | Newsmax.com

COVID Vaccine "Safe and Effective" Narrative Collapses On Camera | ZeroHedge

Pfizer Inc. (NYSE:PFE) Shares Acquired by Harmony Asset Management LLC

Harmony Asset Management LLC Grows Stock Position in Pfizer Inc. (NYSE:PFE)

Trade Spotlight: How should you trade Grindwell Norton, Morepen Labs, Astral, Aditya Birla Capital, Pfizer, Clean Science and others on May 23?

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

Castleark Management LLC Has $79,000 Stock Position in Pfizer Inc. (NYSE:PFE)

Financial Avengers Inc. Acquires 24,642 Shares of Pfizer Inc. (NYSE:PFE)

SK Bioscience prevails over Pfizer in pneumococcal vaccine dispute

Ames National Corp Acquires New Shares in Pfizer Inc. (NYSE:PFE)

Css LLC Il Trims Stock Position in Pfizer Inc. (NYSE:PFE)

Woodline Partners LP Boosts Stake in Pfizer Inc. (NYSE:PFE)

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation | CNN

Dixon Tech, ICICI Securities & more: Top stocks on broker's radar for May 22 - Times of India

Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug

Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal

Pfizer, GITAM University Empower Rural Women with Employment through Pfizer Autonomous Teams Program

Health officials hid myocarditis risks from COVID vaccines, report alleges | Fox News

FDA expands COVID vaccine warning about heart side effect risk for young males

White Knight Strategic Wealth Advisors LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Shares Sold by McIlrath & Eck LLC

Giant U.S. companies are rushing to Europe to borrow money

Biden officials knew about, downplayed COVID-19 vaccine risks, Senate report claims

White Knight Strategic Wealth Advisors LLC Increases Position in Pfizer Inc. (NYSE:PFE)

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | The Manila Times

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | Morningstar

Pfizer Inc. (NYSE:PFE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Giant US companies are rushing to Europe to borrow money

Zimmer Partners LP Makes New Investment in Pfizer Inc. (NYSE:PFE)

iSAM Funds UK Ltd Purchases New Shares in Pfizer Inc. (NYSE:PFE)

SK Bioscience Wins Patent Lawsuit Against Pfizer Over 13-valent Pneumococcal Conjugate Vaccine

SK bioscience wins patent dispute against Pfizer over pneumococcal vaccine

Jubilant Pharmova Share Price Today Up 7%

Centralized lists could improve surgery wait times in Canada, study says | Watch News Videos Online

Health Matters: Doctor discusses measles, ticks, sunscreen and more | Watch News Videos Online

Improved functional assessment in cancer patients using home-based digital technologies

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | Taiwan News | May. 21, 2025 20:00

Pfizer (NYSE:PFE) Trading 0.4% Higher - Should You Buy?

Pfizer-GITAM to provide rural women jobs through Pfizer Autonomous Teams Programme

Pfizer to hold AGM

FDA advisers recommend COVID boosters for 65 and older, reject broad approval

Pfizer Pacing for 4th Day of Gains

Pfizer inks deal with China's 3SBio | The Manila Times

Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival | Morningstar

Trump's MFN model may erode Big pharma's 50% US profits, analysts suggest

Top news of the day: Special Court grants bail to gold smuggling suspects; Ashoka University associate professor sent to judicial custody; SC hears petitions on Waqf Act, and more

Zimmer Partners LP Acquires New Shares in Pfizer Inc. (NYSE:PFE)

Pfizer strikes deal with China's 3SBio to license cancer drug

Lupin Share Price Today Down 3%

Lantern Wealth Advisors LLC Purchases 882 Shares of Pfizer Inc. (NYSE:PFE)

WBI Investments LLC Makes New Investment in Pfizer Inc. (NYSE:PFE)
Pfizer Q4 net profit jumps 85% to ₹331 crore - The Hindu

Stocks Surged: Sensex falls! But these stocks gained over 10% on BSE - The Economic Times
Pfizer Q4 net profit jumps 85% to ₹331 crore; revenue rises 8.3% | Company Results - Business Standard

St. Clair Advisors LLC Acquires Shares of 35,967 Pfizer Inc. (NYSE:PFE)

Triglav Skladi D.O.O. Takes Position in Pfizer Inc. (NYSE:PFE)

Two Sigma Advisers LP Sells 7,622,100 Shares of Pfizer Inc. (NYSE:PFE)

Pfizer Q4 results: Net profit jumps 85% to Rs 330.94 crore

Two Sigma Investments LP Reduces Position in Pfizer Inc. (NYSE:PFE)

Volumes jump at Pfizer Ltd counter | Capital Market News - Business Standard

Board of Pfizer recommends special dividend | Capital Market News - Business Standard

Dividend bonanza alert! This Pharma stock shares jump 11% after Rs 165 per share payout - biggest in 5 years | Zee Business

Pfizer shares jump 11% as profit soars 85% YoY in Q4FY25

Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y

Stocks Surged: Sensex falls! But these stocks are up over 10% on BSE - The Economic Times

Pfizer bets $6B+ on 3Sbio's bispecific PD-1/VEGF antibody | BioWorld

Pfizer share price rises 12% today. Here's why - India Today

Pfizer Share Price Today Up 11%

Pfizer Licenses 3SBio Cancer Drug for Record $1.2 Billion (2)

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25 | Markets News - Business Standard

Pfizer shares jump 12% today as Q4 FY25 profit surges 85%

Biotech Company 3SBio's Shares Surge After $6 Billion Licensing Deal With Pfizer | Morningstar

Pfizer Inc. (PFE) Inks $6 Billion Cancer Drug Licensing Agreement with China's 3SBio - Insider Monkey

Pfizer shares in focus: Rs 165 dividend, 85% rise in Q4 net profit

Pfizer standalone net profit rises 85.03% in the March 2025 quarter | Capital Market News - Business Standard

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

China's 3SBio Shares Surge On Up To $6 Bln Cancer Drug Licensing Deal With Pfizer

Pfizer enters into exclusive licensing agreement worth $4.8 B with China's 3SBio

Pfizer gallops after good Q4 outcome

Cancer treatment paradigms in the precision medicine era

Pfizer share price rises 13% post Q4 Results, dividend announcement despite stock Market crash: Do you own?

Trustco Bank Corp N Y Reduces Position in Pfizer Inc. (NYSE:PFE)

House Probes Pfizer's Delay Of COVID Jab To Influence 2020 Election | ZeroHedge

Texas Bank & Trust Co Acquires New Position in Pfizer Inc. (NYSE:PFE)

Iterum Therapeutics Announces Extension of Term of Promissory Note | The Manila Times
PFIZER news

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow

Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;

Morning Note: UK Inflation Surprises Higher; Mideast Tensions Fuel Oil, Gold